Main Article Content
Abstract
Keywords
Article Details
-
Folia Medica Indonesiana is a scientific peer-reviewed article which freely available to be accessed, downloaded, and used for research purposes. Folia Medica Indonesiana (p-ISSN: 2541-1012; e-ISSN: 2528-2018) is licensed under a Creative Commons Attribution 4.0 International License. Manuscripts submitted to Folia Medica Indonesiana are published under the terms of the Creative Commons License. The terms of the license are:
Attribution ” You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial ” You may not use the material for commercial purposes.
ShareAlike ” If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions ” You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
You are free to :
Share ” copy and redistribute the material in any medium or format.
Adapt ” remix, transform, and build upon the material.
References
- Bui AL, Horwich TB, Fonarow GC (2011). Epidemiology and risk profile of heart failure. Nature Reviews Cardiology 8, 30-41
- Callender T, Woodward M, Roth G, Farzadfar F, Lemarie JC, Gicquel S, Atherton J, Rahimzadeh S, Ghaziani M, Shaikh M, Bennett D, Patel A, Lam CSP, Sliwa K, Barretto A, Siswanto BB, Diaz A, Herpin D, Krum H, Eliasz T, Forbes A, Kiszely A, Khosla R, Petrinic T, Praveen D, Shrivastava R, Xin D, MacMahon S, McMurray J, Rahimi K (2014). Heart failure care in low-and middle-income countries: a systematic review and meta-analysis. PLoS Medicine 11, e1001699
- Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, Kosiborod M, Portnay EL, Sokol SI, Bader F, Krumholz HM (2005). The obesity paradox: body mass index and outcomes in patients with heart failure. Archives of Internal Medicine 165, 55-61
- Fitzgibbons TP, Hardy OT, Lessard D, Gore JM, Yarzebski J, Goldberg RJ (2009). Body mass index, treatment practices, and mortality in patients with acute heart failure. Coronary Artery Disease 20, 536-543
- Gruberg L, Weissman NJ, Waksman R, Fuchs S, Deible R, Pinnow EE, Ahmed LM, Kent KM, Pichard AD, Suddath WO, Satler LF, Lindsay J Jr (2002). The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Colle Cardiol 39, 578-584
- Haass M, Kitzman DW, Anand IS, Miller A, Zile MR, Massie BM, Carson PE (2011). Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Circulation Heart Failure 4, 324-331
- He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK (2001). Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Archives of Internal Medicine 161, 996-1002
- Joseph SM, Cedars AM, Ewald GA, Geltman EM, Mann DL (2009). Acute decompensated heart failure: contemporary medical management. Texas Heart Institute Journal 36, 510-520
- Kenchaiah S, Evans JC, Levy D, Wilson PWF, Benjamin EJ, Larson MG, Kannel WB, Vasan RS (2002). Obesity and the risk of heart failure. N Engl J Med 347, 305-313
- Kenchaiah S, Pocock SJ, Wang D, Finn PV, Zornoff LA, Skali H, Pfeffer MA, Yusuf S, Swedberg K, Michelson EL, Granger CB, McMurray JJ, Solomon SD; CHARM Investigators (2007). Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation 116, 627-636
- Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA (2008). Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 156, 13-22
- Siswanto BB, Radi B, Kalim H, Santoso A, Suryawan R, Erwinanto, Antono E, Santoso T (2010). Heart failure in NCVC Jakarta and 5 hospitals in Indonesia. CVD Prevention and Control 5, 35-38
- WHO (2008). The Global Burden of Disease 2004 Update. Geneva: WHO Press
- Zamora E, Lupón J, Urrutia A, González B, Mas D, Pascual T, Domingo M, Valle V (2007). Does body mass index influence mortality in patients with heart failure? Rev Esp Cardiol 60, 1127-1134
References
Bui AL, Horwich TB, Fonarow GC (2011). Epidemiology and risk profile of heart failure. Nature Reviews Cardiology 8, 30-41
Callender T, Woodward M, Roth G, Farzadfar F, Lemarie JC, Gicquel S, Atherton J, Rahimzadeh S, Ghaziani M, Shaikh M, Bennett D, Patel A, Lam CSP, Sliwa K, Barretto A, Siswanto BB, Diaz A, Herpin D, Krum H, Eliasz T, Forbes A, Kiszely A, Khosla R, Petrinic T, Praveen D, Shrivastava R, Xin D, MacMahon S, McMurray J, Rahimi K (2014). Heart failure care in low-and middle-income countries: a systematic review and meta-analysis. PLoS Medicine 11, e1001699
Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, Kosiborod M, Portnay EL, Sokol SI, Bader F, Krumholz HM (2005). The obesity paradox: body mass index and outcomes in patients with heart failure. Archives of Internal Medicine 165, 55-61
Fitzgibbons TP, Hardy OT, Lessard D, Gore JM, Yarzebski J, Goldberg RJ (2009). Body mass index, treatment practices, and mortality in patients with acute heart failure. Coronary Artery Disease 20, 536-543
Gruberg L, Weissman NJ, Waksman R, Fuchs S, Deible R, Pinnow EE, Ahmed LM, Kent KM, Pichard AD, Suddath WO, Satler LF, Lindsay J Jr (2002). The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Colle Cardiol 39, 578-584
Haass M, Kitzman DW, Anand IS, Miller A, Zile MR, Massie BM, Carson PE (2011). Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Circulation Heart Failure 4, 324-331
He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK (2001). Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Archives of Internal Medicine 161, 996-1002
Joseph SM, Cedars AM, Ewald GA, Geltman EM, Mann DL (2009). Acute decompensated heart failure: contemporary medical management. Texas Heart Institute Journal 36, 510-520
Kenchaiah S, Evans JC, Levy D, Wilson PWF, Benjamin EJ, Larson MG, Kannel WB, Vasan RS (2002). Obesity and the risk of heart failure. N Engl J Med 347, 305-313
Kenchaiah S, Pocock SJ, Wang D, Finn PV, Zornoff LA, Skali H, Pfeffer MA, Yusuf S, Swedberg K, Michelson EL, Granger CB, McMurray JJ, Solomon SD; CHARM Investigators (2007). Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation 116, 627-636
Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA (2008). Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 156, 13-22
Siswanto BB, Radi B, Kalim H, Santoso A, Suryawan R, Erwinanto, Antono E, Santoso T (2010). Heart failure in NCVC Jakarta and 5 hospitals in Indonesia. CVD Prevention and Control 5, 35-38
WHO (2008). The Global Burden of Disease 2004 Update. Geneva: WHO Press
Zamora E, Lupón J, Urrutia A, González B, Mas D, Pascual T, Domingo M, Valle V (2007). Does body mass index influence mortality in patients with heart failure? Rev Esp Cardiol 60, 1127-1134